Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-15 Purchase |
2021-09-15 4:37 pm |
DiaMedica Therapeutics Inc. | DMAC | ALCORN HARRY W JR SVP, Clinical Operations |
15,000 | $3.7973 | $56,960 | 43,981 (Indirect Direct) |
View |
2021-08-16 Purchase |
2021-08-17 4:11 pm |
DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director |
44,950 | $3.15 | $141,593 | 44,950 (Direct) |
View |
2021-08-16 Purchase |
2021-08-17 4:05 pm |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
15,000 | $3.2709 | $49,064 | 95,565 (Direct) |
View |
2021-08-16 Purchase |
2021-08-16 4:27 pm |
DiaMedica Therapeutics Inc. | DMAC | ALCORN HARRY W JR Senior VP, Clinical Operations |
20,721 | $3.0913 | $64,054 | 28,981 (Indirect Direct) |
View |
2021-08-16 Purchase |
2021-08-16 4:19 pm |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
5,000 | $3.14 | $15,700 | 35,804 (Direct) |
View |
2021-08-16 Purchase |
2021-08-16 4:10 pm |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
10,000 | $3.1463 | $31,463 | 22,290 (Direct) |
View |
2020-12-04 Purchase |
2020-12-04 5:46 pm |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
10,000 | $5.3697 | $53,697 | 70,846 (Direct) |
View |
2020-11-20 Purchase |
2020-11-23 4:22 pm |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
15,000 | $4.2608 | $63,912 | 189,009 (Indirect Direct) |
View |
2020-11-09 Purchase |
2020-11-10 08:16 am |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
2,000 | $4.1933 | $8,387 | 12,290 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-01-03 Option Award |
2022-01-03 4:39 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director |
11,182 | $3.58 | 56,132 (Direct) |
View |
2022-01-03 Option Award |
2022-01-03 4:26 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
23,762 | $3.58 | 119,327 (Direct) |
View |
2022-01-03 Option Award |
2022-01-03 4:21 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
16,773 | $3.58 | 38,509 (Direct) |
View |
2022-01-03 Option Award |
2022-01-03 4:09 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
15,026 | $3.58 | 211,054 (Direct) |
View |
2021-07-28 Option Award |
2021-07-29 9:18 pm |
N/A 2031-07-27 |
DiaMedica Therapeutics Inc. | DMAC | Gilman Sydney A. VP, Regulatory Affairs |
25,000 | $0 | 25,000 (Direct) |
View |
2021-07-28 Option Award |
2021-07-29 9:14 pm |
N/A 2031-07-27 |
DiaMedica Therapeutics Inc. | DMAC | ALCORN HARRY W JR Chief Medical Officer |
60,000 | $0 | 68,260 (Direct) |
View |
2021-07-28 Option Award |
2021-07-29 9:07 pm |
N/A 2031-07-27 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
175,000 | $0 | 205,804 (Direct) |
View |
2021-07-28 Option Award |
2021-07-29 9:02 pm |
N/A 2031-07-27 |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
60,000 | $0 | 72,290 (Direct) |
View |
2021-07-15 Option Award |
2021-07-16 4:52 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
9,393 | $0 | 205,843 (Direct) |
View |
2021-07-15 Option Award |
2021-07-16 4:45 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
9,393 | $0 | 31,340 (Direct) |
View |
2021-07-15 Option Award |
2021-07-16 4:40 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
13,150 | $0 | 93,715 (Direct) |
View |
2021-07-15 Option Award |
2021-07-16 4:35 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director |
18,786 | $0 | 18,786 (Direct) |
View |
2021-07-15 Option Award |
2021-07-16 4:21 pm |
N/A 2031-07-14 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
18,786 | $0 | 18,786 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 4:33 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
7,441 | $8.23 | 196,450 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 4:21 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
7,745 | $8.23 | 21,947 (Direct) |
View |
2021-01-01 Option Award |
2021-01-04 4:12 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
9,719 | $8.23 | 80,565 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 5:36 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Gilman Sydney A. VP, Regulatory Affairs |
17,500 | $0 | 17,500 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 5:28 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
35,000 | $0 | 45,290 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 5:19 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
56,000 | $0 | 86,804 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 5:10 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | ALCORN HARRY W JR Chief Medical Officer |
35,000 | $0 | 43,260 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:59 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
13,306 | $0 | 187,315 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:59 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
7,784 | $4.59 | 187,315 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:49 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
13,306 | $0 | 27,508 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:49 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
8,102 | $4.59 | 27,508 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:33 pm |
N/A 2030-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
19,220 | $0 | 80,066 (Direct) |
View |
2020-06-01 Option Award |
2020-06-02 4:33 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
10,168 | $4.59 | 80,066 (Direct) |
View |